Marshall Wace, LLP Lantheus Holdings, Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 8,326 shares of LNTH stock, worth $894,129. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,326

Previous 457,062 98.18%

Holding current value

$894,129

Previous $28.4 Million 97.65%

% of portfolio

0.0%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$58.87 - $83.05 $26.4 Million - $37.3 Million	-448,736 Reduced 98.18%	8,326 $668,000
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $2.68 Million - $3.58 Million	52,381 Added 12.94%	457,062 $28.4 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $20 Million - $28 Million	-359,919 Reduced 47.07%	404,681 $25.1 Million
Q3 2023 Nov 14, 2023	BUY	$60.27 - $90.75 $30.9 Million - $46.5 Million	512,686 Added 203.52%	764,600 $53.1 Million
Q2 2023 Aug 14, 2023	SELL	$82.41 - $99.65 $69 Million - $83.4 Million	-837,148 Reduced 76.87%	251,914 $21.1 Million
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $40.8 Million - $70.7 Million	853,243 Added 361.82%	1,089,062 $89.9 Million
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $12.6 Million - $20.1 Million	-259,304 Reduced 52.37%	235,819 $12 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $23.4 Million - $32.9 Million	381,320 Added 335.07%	495,123 $34.8 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $822,103 - $1.08 Million	14,802 Added 14.95%	113,803 $7.51 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $30,957 - $72,216	-1,275 Reduced 1.27%	99,001 $5.48 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $2.26 Million - $3.05 Million	100,276 New	100,276 $2.9 Million
Q3 2020 Nov 16, 2020	SELL	$11.98 - $16.34 $1.29 Million - $1.76 Million	-107,726 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$10.34 - $15.51 $1.81 Million - $2.72 Million	-175,367 Reduced 61.95%	107,726 $1.54 Million
Q1 2020 May 15, 2020	BUY	$9.11 - $20.05 $2.58 Million - $5.68 Million	283,093 New	283,093 $3.61 Million
Q4 2019 Feb 14, 2020	SELL	$18.47 - $24.03 $66,344 - $86,315	-3,592 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$21.01 - $28.94 $581,031 - $800,335	-27,655 Reduced 88.5%	3,592 $90,000
Q2 2019 Aug 14, 2019	BUY	$23.33 - $28.3 $728,992 - $884,290	31,247 New	31,247 $884,000
Q1 2019 May 14, 2019	SELL	$14.93 - $25.1 $145,059 - $243,871	-9,716 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$12.68 - $19.01 $123,198 - $184,701	9,716 New	9,716 $153,000
Q2 2018 Aug 14, 2018	SELL	$13.65 - $18.7 $197,925 - $271,150	-14,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.85 - $24.3 $215,325 - $352,350	14,500 New	14,500 $231,000

Others Institutions Holding LNTH

# of Institutions

495

Shares Held

67.2M

Call Options Held

1.19M

Put Options Held

829K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.38B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Lantheus Holdings, Inc. Transaction History